Ribometrix
Small molecule drugs that target functional 3D RNA structures to treat human diseases.
Seedtable Score
28
Startups
4
Funding Rounds
$52.8m
Money raised
Overview
Small molecule drugs that target functional 3D RNA structures to treat human diseases.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ka*** Wa**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Ribometrix has raised a total of $37.5m in funding over 4 rounds.
Key Insights:
- Ribometrix Series A round, November 2018: $30m
- Ribometrix Seed round, October 2017: $7.5m
- Ribometrix funding round, September 2019: $7.8m
- Ribometrix Inc funding round, November 2017: $7.5m
Ribometrix Series A round, November 2018
$30m
Ribometrix Seed round, October 2017
$7.5m
Ribometrix funding round, September 2019
$7.8m
Ribometrix Inc funding round, November 2017
$7.5m
Industries
Ribometrix is active in the following industries: